Professor Moji Christianah Adeyeye

Professor Moji Christianah Adeyeye

Director General, NAFDAC

Building Sustainable Capacity for Pharmaceutical Research & Development and Manufacturing in Africa

Professor Moji Christianah Adeyeye is the current director general of NAFDAC. She is the founder of Drugs for AIDS and HIV patients, a non profit organization committed to prevention, education, care and treatment of HIV/AIDS children in Nigeria 

She is the founding chair of Biopharmaceutical Sciences and professor of pharmaceuticals and drug product evaluation at the college of pharmacy, Roosevelt university in Schaumburg, Illinois.

She was the professor of pharmaceutics and manufacturing for 21 years at Duquesne university in Pittsburgh, PA. She is senior Fulbright Scholar and Specialist and 2008 AAPS

She has earned her B.S and M.S and PhD from the University of Nigeria, Nssuka, and university of Georgia, Athens, GA. She has mentored over 15 PhD and M.S candidates. She has patents, 55 peer-reviewed manuscripts, book chapters and books and more than 140 scientific presentations.


Corporate Information

The IAS PHARMA Inaugural Copyright 2023 is organized by Xcene Research, an African Contract Research Organization committed to providing clinical trials access to a more diverse population in Africa.

Contact Address

Xcene Research Corporate Office
1 Ogunsiji Close, S&B Tejuosho Estate, Allen Avenue Ikeja, Lagos Nigeria

Impact Africa Summit


Quick Links

Follow Us On:

  • icon
  • icon
  • icon
  • icon

Hotel Accommodations

Hotel: Lagos Oriental Hotel
Address: 3 Lekki – Epe, Expy, Victoria Island, Lagos
Contact : +2347026960065
Discount Code : IASPharma23

Hotel: Tudor Hotel
Address: Lekki Phase 1
Contact : +2348167799210
Discount Code : IASPharma23


Company : Sixth Motors
Contact: +2347035158901
Discount Code: IASPharma23

Venue Information

Signup For Updates

Get regular updates and hear the latest news and advancements from our team. Signup for email updates

Copyright © Copyright 2023 Impact Africa Summit. All Rights Reserved.